Industry Context — Common BS Fingerprints in Medical Devices, Pharma & Biotech
EUCRISA (Pfizer)
(https://eucrisa.com) 📸 Data Snapshot: May 30, 2026Analyze the raw signals below. How would a machine score this business’s credibility?
Here are the exact signals captured from up to six pages of the site — the same raw inputs the evaluation engine analyzed. They are grouped by signal type so you can weigh each the way the machine does.
🏗️ Semantic Structure — heading hierarchy & page identity (Info Density · Commodity Fingerprint)
HOMEPAGE Eczema Treatment EUCRISA® (crisaborole) 3 months and Up | Safety Info (https://eucrisa.com)
Eczema Treatment EUCRISA® (crisaborole) 3 months and Up | Safety Info
Learn more about EUCRISA®, a 100% steroid-free prescription ointment for mild-to-moderate eczema in adults and children ages 3 months and older.
NAV_HEADER_HEADING_REPEATED_BODY_FOOTER Learn About Eczema Treatment EUCRISA® (crisaborole) | Safety Info (https://eucrisa.com/learn-about-eucrisa/)
Learn About Eczema Treatment EUCRISA® (crisaborole) | Safety Info
See how EUCRISA® works above and below the skin’s surface to treat mild-to-moderate eczema in adults and children ages 3 months and older.
NAV_HEADER_HEADING_REPEATED_FOOTER Sign up for EUCRISA® (crisaborole) Information (https://eucrisa.com/eucrisa-information-sign-up/)
Sign up for EUCRISA® (crisaborole) Information
Sign up to receive information about EUCRISA®, a 100% steroid-free Rx topical ointment for adults and children ages 3 months and older. See safety info.
NAV_HEADER_REPEATED_BODY_FOOTER Pfizer Dermatology Patient Access | EUCRISA® (crisaborole) (https://eucrisa.com/pfizer-derm-patient-access/)
Pfizer Dermatology Patient Access | EUCRISA® (crisaborole)
Discover how Pfizer Dermatology Patient Access offers EUCRISA® patients personalized support, resources, and savings options.
📝 The Narrative — clean text per page (Info Density · Semantic Coherence)
HOMEPAGE (https://eucrisa.com) Eczema Treatment EUCRISA® (crisaborole) 3 months and Up | Safety Info
[IMG: Previous slide] [IMG: Next slide] For mild-to-moderate eczema in ages 3 months & up Prescription EUCRISA works above and below the skin's surface *Learn More *The specific way EUCRISA works is not well defined. Crisaborole is combined with our proprietary Emollient-Rich Vehicle ointment. Ointments contain emollients, which can help lock in moisture and soften the skin. 100% steroid-free EUCRISA can be used almost everywhere on almost everybody *Learn More *For topical use only. Do not use in eyes, mouth, or vagina. EUCRISA can be used on all skin tones Learn More For mild-to-moderate eczema Prescription EUCRISA can be part of a long-term treatment plan Learn More [IMG: works at and below the skin] See it in action [IMG: 3 months and up FDA approved for babies] Approved for babies [IMG: 100% steroid free] Learn moreThe specific way EUCRISA works is not well defined. [H1] See how you could pay as little as $10 on EUCRISA Eligibility required. No membership fees. This is not health insurance. Individual savings limited to $970 per tube or $3,880 in maximum total savings per calendar year. Only for use with commercial insurance. If you are enrolled in a state or federally funded prescription insurance program, you may not use the copay card. Terms and conditions apply Before • Day 1 After • Day 29 See results fromour clinical trials. Photos of a patient treated with EUCRISA in a clinical trial of patients 2 years and older. Individual results may vary. Not everyone will respond to treatment with EUCRISA. How does EUCRISA work?EUCRISA gets to work on the surface of your skin.But it doesn’t stop there.Take a deeper look. The specific way EUCRISA works is not well defined. [H2] corona msg IMPORTANT SAFETY INFORMATION & USE IMPORTANT SAFETY INFORMATION Do not use EUCRISA if you are allergic to crisaborole or any of the ingredients in EUCRISA. EUCRISA may cause side effects including allergic reactions at or near the application site or at a distant site. These can be serious and may include trouble breathing, throat or chest tightness, feeling faint, swelling of the face, eyelids, lips, mouth, tongue or throat, hives, itching, and redness. If you have any of these symptoms, stop using EUCRISA and get medical help right away. The most common side effect of EUCRISA is application site pain, such as burning or stinging. EUCRISA is for use on skin (topical use) only. Do not use EUCRISA in your eyes, mouth, or vagina. INDICATION EUCRISA is a prescription ointment used on the skin (topical) to treat mild-to-moderate eczema (atopic dermatitis) in adults and children 3 months of age and older. See full Prescribing Information. IMPORTANT SAFETY INFORMATION & USE IMPORTANT SAFETY INFORMATION Do not use EUCRISA if you are allergic to crisaborole or any of the ingredients in EUCRISA. EUCRISA may cause side effects including allergic reactions at or near the application site or at a distant site. These can be serious and may include trouble breathing, throat or chest tightness, feeling faint, swelling of the face, eyelids, lips, mouth, tongue or throat, hives, itching, and redness. If you have any of these symptoms, stop using EUCRISA and get medical help right away. The most common side effect of EUCRISA is application site pain, such as burning or stinging. EUCRISA is for use on skin (topical use) only. Do not use EUCRISA in your eyes, mouth, or vagina. INDICATION EUCRISA is a prescription ointment used on the skin (topical) to treat mild-to-moderate eczema (atopic dermatitis) in adults and children 3 months of age and older. See full Prescribing Information.
SUB-PAGE (https://eucrisa.com/learn-about-eucrisa/) Learn About Eczema Treatment EUCRISA® (crisaborole) | Safety Info
[H1] EUCRISA works above and below the skin’s surface When EUCRISA was approved in 2016, it was the first FDA-approved topical prescription treatment for eczema in over a decade. It is a steroid-free ointment for people with mild-to-moderate eczema and can be used on all skin tones from nose to toes, for adults and children as young as 3 months old. EUCRISA is for topical use only. Do not use in eyes, mouth, or vagina. You can see eczema on the surface of your skin, but there may also be irritation below that you can’t see. EUCRISA works both above and below the skin to treat eczema. The active ingredient, crisaborole 2%, acts deep within your skin cells to target an enzyme called PDE4 (phosphodiesterase 4). The specific way EUCRISA works is not well defined. Crisaborole is combined with our proprietary Emollient-Rich Vehicle ointment. Ointments contain emollients, which can help lock in moisture and soften the skin. Have more questions? See how telemedicine may help you get answers. [H2] EUCRISA PROPRIETARY OINTMENT: [H2] EMOLLIENT-RICH VEHICLE (E.R.V.) [H3] DID YOU KNOW EUCRISA: [IMG: 100% steroid free] Is 100% steroid free [IMG: no added fragrance] Has no added fragrance [IMG: paraben free] Is paraben free [IMG: contains no animal by-products] Contains no animal by-products [H2] corona msg
SUB-PAGE (https://eucrisa.com/eucrisa-information-sign-up/) Sign up for EUCRISA® (crisaborole) Information
[IMG: Pfizer Dermatology patient access banner] [H1] Keep up to date with information about EUCRISA * Before we can email you helpful information about EUCRISA, we’ll just need some information from you. [H2] corona msg IMPORTANT SAFETY INFORMATION & USE IMPORTANT SAFETY INFORMATION Do not use EUCRISA if you are allergic to crisaborole or any of the ingredients in EUCRISA. EUCRISA may cause side effects including allergic reactions at or near the application site or at a distant site. These can be serious and may include trouble breathing, throat or chest tightness, feeling faint, swelling of the face, eyelids, lips, mouth, tongue or throat, hives, itching, and redness. If you have any of these symptoms, stop using EUCRISA and get medical help right away. The most common side effect of EUCRISA is application site pain, such as burning or stinging. EUCRISA is for use on skin (topical use) only. Do not use EUCRISA in your eyes, mouth, or vagina. INDICATION EUCRISA is a prescription ointment used on the skin (topical) to treat mild-to-moderate eczema (atopic dermatitis) in adults and children 3 months of age and older. See full Prescribing Information. IMPORTANT SAFETY INFORMATION & USE IMPORTANT SAFETY INFORMATION Do not use EUCRISA if you are allergic to crisaborole or any of the ingredients in EUCRISA. EUCRISA may cause side effects including allergic reactions at or near the application site or at a distant site. These can be serious and may include trouble breathing, throat or chest tightness, feeling faint, swelling of the face, eyelids, lips, mouth, tongue or throat, hives, itching, and redness. If you have any of these symptoms, stop using EUCRISA and get medical help right away. The most common side effect of EUCRISA is application site pain, such as burning or stinging. EUCRISA is for use on skin (topical use) only. Do not use EUCRISA in your eyes, mouth, or vagina. INDICATION EUCRISA is a prescription ointment used on the skin (topical) to treat mild-to-moderate eczema (atopic dermatitis) in adults and children 3 months of age and older. See full Prescribing Information.
SUB-PAGE (https://eucrisa.com/pfizer-derm-patient-access/) Pfizer Dermatology Patient Access | EUCRISA® (crisaborole)
[IMG: Pfizer Dermatology patient access banner] [H1] We're here to help! Pfizer Dermatology Patient Access offers you personalized support, resources, and savings options every step of the way. This includes: [H2] Eucrisa 4 you Savings Offer on EUCRISA for eligible patientsA live Support RepresentativeOngoing EUCRISA information [H2] Savings for eligible patients [H2] Want to save on EUCRISA?* Eligible patients pay as little as: [IMG: see how you could pay as little as $10 on EUCRISA (crisaborole) with the copay savings card. T&C apply.] $ 10 Patients with commercial insurance that covers EUCRISA *$ 100 Patients with commercial insurance that does not cover EUCRISA *$100Patients with commercial insurance that does not cover EUCRISA*Sign up to see how you could pay as little as $10 with the Copay Savings Card. *Sign up for Pfizer Dermatology Patient Access *Eligibility required. No membership fees. This is not health insurance. Individual savings limited to $970 per tube or $3,880 in maximum total savings per calendar year. Only for use with commercial insurance. If you are enrolled in a state or federally funded prescription insurance program, you may not use the copay card. Terms and conditions apply. *Eligibility required. No membership fees. Individual savings limited to $970 per tube or $3,880 in maximum total savings per calendar year. Only for use with commercial insurance. If you are enrolled in a state or federally funded prescription insurance program, you may not use the copay card.Terms and conditions apply. For details on CIBINQO, please see full Prescribing Information, including BOXED WARNING , and Medication Guide.You may also call 1-833-956-DERM( 1-833-956-3376) to request your Copay Savings Card, or ask your doctor. [H2] Personalized support to help you with your Insurance for EUCRISA Connect with a live Support Representative to help you understand coverage and explore financial assistance options. Call1-833-956-DERM(1-833-956-3376)Mon-Fri8 AM - 8 PM ETor ask your doctor's office. [H2] EUCRISA Information Sign Up [H2] Get even more support Sign up for exclusive emails to receive additional tools, tips, and information about EUCRISA. Sign up for Pfizer Dermatology Patient Access [H2] corona msg IMPORTANT SAFETY INFORMATION & USE IMPORTANT SAFETY INFORMATION Do not use EUCRISA if you are allergic to crisaborole or any of the ingredients in EUCRISA. EUCRISA may cause side effects including allergic reactions at or near the application site or at a distant site. These can be serious and may include trouble breathing, throat or chest tightness, feeling faint, swelling of the face, eyelids, lips, mouth, tongue or throat, hives, itching, and redness. If you have any of these symptoms, stop using EUCRISA and get medical help right away. The most common side effect of EUCRISA is application site pain, such as burning or stinging. EUCRISA is for use on skin (topical use) only. Do not use EUCRISA in your eyes, mouth, or vagina. INDICATION EUCRISA is a prescription ointment used on the skin (topical) to treat mild-to-moderate eczema (atopic dermatitis) in adults and children 3 months of age and older. See full Prescribing Information. IMPORTANT SAFETY INFORMATION & USE IMPORTANT SAFETY INFORMATION Do not use EUCRISA if you are allergic to crisaborole or any of the ingredients in EUCRISA. EUCRISA may cause side effects including allergic reactions at or near the application site or at a distant site. These can be serious and may include trouble breathing, throat or chest tightness, feeling faint, swelling of the face, eyelids, lips, mouth, tongue or throat, hives, itching, and redness. If you have any of these symptoms, stop using EUCRISA and get medical help right away. The most common side effect of EUCRISA is application site pain, such as burning or stinging. EUCRISA is for use on skin (topical use) only. Do not use EUCRISA in your eyes, mouth, or vagina. INDICATION EUCRISA is a prescription ointment used on the skin (topical) to treat mild-to-moderate eczema (atopic dermatitis) in adults and children 3 months of age and older. See full Prescribing Information.
🛡️ Trust Signals — reviews, proof links, trust-theatre flag (Trust & Proof)
| Page | Reviews | Proof links |
|---|---|---|
| / (home) | 1 | 0 |
| /learn-about-eucrisa/ | 1 | 0 |
| /eucrisa-information-sign-up/ | 1 | 0 |
| /pfizer-derm-patient-access/ | 1 | 0 |
🔗 Identity & Technical Layer — schema JSON-LD: identity chains, entity gaps (Identity & Authority)
Your Diagnosis
Before revealing the machine’s verdict, predict the BS score for each signal. Higher = more BS (more fluff, less verifiable substance). Drag each slider, then submit to compare your judgment against the engine.
Stuck? Reveal the heuristic lens — how the deterministic page-auditor reads each signal (no AI, pure pattern rules)
These are the structural rules a local, deterministic auditor applies — the same lens you can use to judge each signal. They describe what to look for, not this company’s result.
Classify each sentence as substantive or hollow. Grounding markers — numbers, currencies, dates, technical units, named entities — outweigh marketing adjectives. When fluff sits right next to hard evidence, the fluff is forgiven.
Pull the main entities out of the H1, then check whether they actually recur through the body. A page that announces one thing and then talks about another drifts. Headings with no real sentences underneath read as pseudo-substance.
Count trust words (review, testimonial, rating, verified) against real outbound proof links (Google, Trustpilot, Clutch, G2, Yelp). Lots of trust language with zero verification links is trust theatre. Unlinked logo galleries count against it.
Look at how much sentence length varies. Natural writing varies its rhythm; templated or mass-produced copy is statistically uniform. Very low variation reads as commodity content — unless unique named entities break the pattern.
Inspect the JSON-LD. Is there an Organization or Person schema, and does it carry sameAs links to real external profiles (LinkedIn, socials)? Missing schema or no identity declaration signals an anonymous entity.
Want to apply this lens yourself? The free BS Indicator Chrome extension runs these heuristic checks live on any page. Bear in mind it is a single-page, deterministic tool — it relies only on pattern rules for the page in front of it and does not perform the cross-page semantic correlation this audit uses, so its readout is a starting lens, not the full verdict.
Based on 784 businesses audited.
Medical Devices, Pharma & Biotech BS: EUCRISA (Pfizer) (eucrisa.com)
EUCRISA is a high-substance pharmaceutical site that suffers from technical neglect and template fatigue. While the clinical and financial claims are specific and well-documented, the null schema and ‘corona msg’ artifacts suggest a brand operating on autopilot. It is low on marketing bullshit but moderately high on technical ‘ghost-brand’ indicators.
First, implement comprehensive Drug and Organization schema to link the product to Pfizer’s digital authority and verify regulatory status. Second, replace the ‘corona msg’ and ‘Footer Main menu’ [H2] tags with descriptive, keyword-rich headings that improve information architecture. Third, include direct citations or outbound links to the peer-reviewed studies supporting the PDE4 target and the 2016 clinical trials. Finally, update the site’s technical structure to eliminate the trust_theatre_flag by either linking reviews to a third-party validator or removing the static review count.
The content perfectly matches the Pharma & Biotech category, specifically focusing on a prescription topical treatment (crisaborole) for atopic dermatitis. It adheres to pharmaceutical regulatory norms by including extensive ‘Important Safety Information’ (ISI) and specific ‘Indication’ blocks.
“The score of 38 is driven primarily by technical authority gaps (null schema) and trust theatre flags (unverified reviews). While the content substance is strong (lowering the score), the presence of template artifacts and the lack of external proof paths prevent it from reaching a 'Minimal BS' rating. The 2026 temporal anchor makes the 2016 approval date appear 'stale,' further contributing to the technical neglect penalty.”
This training module utilizes a snapshot of public data from EUCRISA (Pfizer), captured on May 30, 2026, to demonstrate how machine logic evaluates different types of business narratives.
Purpose: This data is presented under “Fair Use” / “Educational Exception” for the purpose of forensic semantic analysis, allowing users to compare human intuition against machine-generated evaluations.
Notice to EUCRISA (Pfizer): This analysis is part of a non-adversarial audit conducted by 1 Euro SEO. The results provided by 1EuroSEO are intended as professional feedback to help improve any website’s machine-readability and authority signals. The 1EuroSEO BS Detection Tool is a free tool, and anyone can test any company to see how their content is interpreted by AI models.
Any company can use the insights for free and improve its voice by comparing it to industry clichés or competitors. When a company has updated its content, it can always submit a new audit request, which will be reflected in a new current score.
To all users: You are encouraged to visit the live site at https://eucrisa.com to view the most current version of its content and learn from the source what this company is about and what it offers.